BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1364078)

  • 1. [A critical study of conditions for prescription and evaluation criteria of neuroleptic treatment in resistant schizophrenia].
    Petit M; Dollfus S
    Encephale; 1992 Sep; 18 Spec No 3():447-51. PubMed ID: 1364078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
    Jalenques I; Coudert AJ
    Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].
    Jalenques I; Coudert AJ
    Encephale; 1994; 20(6):767-75. PubMed ID: 7875111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term clinical experience with clozapine].
    Gelly F; Chambon O; Marie-Cardine M
    Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
    Stryjer R; Strous R; Bar F; Shaked G; Shiloh R; Rozencwaig S; Grupper D; Buchman N; Kotler M; Rabey JM; Weizman A
    Hum Psychopharmacol; 2004 Jul; 19(5):343-6. PubMed ID: 15252826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopharmacological treatment of treatment-resistant schizophrenia].
    Lublin HK
    Ugeskr Laeger; 1997 Nov; 159(48):7128-33. PubMed ID: 9417718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Profile of the action of neuroleptics in deficit schizophrenia].
    Vanelle JM
    Encephale; 1996 Jun; 22 Spec No 2():33-9. PubMed ID: 8767040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience with clozapine in Woodbridge Hospital.
    Wong KE; Chong SA; Ngui F; Winslow M; Devan GS; Leong OK; Choo CH
    Singapore Med J; 1997 Aug; 38(8):336-8. PubMed ID: 9364887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
    Christison GW; Kirch DG; Wyatt RJ
    Schizophr Bull; 1991; 17(2):217-45. PubMed ID: 1679252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-year naturalistic follow-up of patients receiving clozapine: Report from India.
    Srivastava S; Agarwal A; Sharma M
    Int J Psychiatry Clin Pract; 2002; 6(3):167-71. PubMed ID: 24945204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting drug-free improvement in schizophrenic psychosis.
    Marder SR; van Kammen DP; Docherty JP; Rayner J; Bunney WE
    Arch Gen Psychiatry; 1979 Sep; 36(10):1080-5. PubMed ID: 38763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drs Kane and Correll Reply.
    Kane JM; Correll CU
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32558405
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine versus typical neuroleptic medication for schizophrenia.
    Essali A; Al-Haj Haasan N; Li C; Rathbone J
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD000059. PubMed ID: 19160174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.